However, emerging evidence demonstrated that EZH2 alteration or overexpression plays a key role in inflammatory diseases, such as prostatitis, colitis but also in ischemic stroke and early brain injury (EBI), revealing that its inhibition attenuates neuroinflammation and provides neuroprotective effects [41, 42]. Here, EZH2 is linked to prostatitis.